Bottom line
Is FBT a good fund? The bottom line
FBT is an index technology sector ETF from First Trust.
Its expense ratio is 0.55% — about $55 a year on every $10,000 invested, cheaper than 74% of technology sector funds we track.
It returned +24.1% over one year, +4.3% a year over five years, +6.3% a year over ten (as of Dec 31, 2025, per its prospectus).
With $2.8 billion in net assets and 32 holdings, its largest position is Corcept Therapeutics Inc (5.6%) and the top 10 make up 43.2% of the portfolio.
Updated Nov 19, 2026
What FBT invests in
The First Trust NYSE Arca Biotechnology Index Fund (the Fund ) seeks investment results that correspond generally to the price and yield (before the Funds fees and expenses) of an equity index called the NYSE Arca Biotechnology Index (the Index ).
The Fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the Index. The Fund, using an indexing investment approach, attempts to replicate, before fees and expenses, the performance of the Index. The Index is developed, maintained and sponsored by ICE Data Indices, LLC (the Index Provider ). The Index Provider reserves the right to, at any time, change the number of stocks comprising the Index by adding or deleting one or more stocks, or replacing one or more stocks contained in the Index with one or more substitute stocks of its choice, if in the Index Provider's discretion such addition, deletion or substitution is necessary or appropriate to maintain the quality and/or character of the Index. The Index is a rules-based, equal-weighted equity benchmark designed to track the performance of 30 leading biotechnology…
From the fund's prospectus (filed Apr 30, 2026).
FBT performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| FBT | +24.1% | +4.3% | +6.3% |
| Technology Sector median | +24.0% | +10.0% | +16.7% |
Source: Fund prospectus, as of Dec 31, 2025
What FBT costs
On a $10,000 investment, FBT's 0.55% expense ratio costs about $55 a year. The median technology sector fund charges 0.75%.
FBT top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Corcept Therapeutics Inc CORT | 5.60% |
| 2 | Neogenomics Inc NEO | 5.12% |
| 3 | Veracyte Inc VCYT | 5.10% |
| 4 | Bruker Corp BRKR | 4.32% |
| 5 | Alkermes Plc ALKS | 4.24% |
| 6 | Illumina Inc ILMN | 3.92% |
| 7 | Krystal Biotech Inc KRYS | 3.87% |
| 8 | Natera Inc NTRA | 3.79% |
| 9 | Axsome Therapeutics Inc AXSM | 3.71% |
| 10 | Neurocrine Biosciences Inc NBIX | 3.53% |
Source: SEC Form N-PORT, period ended Jun 30, 2026
The top 10 make up 43.2% of the fund. See all top 25 holdings and asset mix →